Association between autoantibodies to the Ku protein and DPB1

Arthritis and Rheumatism

Volumn 52, Issue 2, 2005, Pages 668-669

  Hirakata, Michito ^a   Suwa, Akira ^a   Kuwana, Masataka ^a   Sato, Shinji ^a   Mimori, Tsuneyo ^b   Hardin, John A ^c  

^a KEIO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; HLA ANTIGEN CLASS 2; HLA DPB1 ANTIGEN; KU ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; GENOTYPE; HLA SYSTEM; HUMAN; IMMUNOBLOTTING; IMMUNOGENETICS; INNATE IMMUNITY; POLYMYOSITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOIMMUNOPRECIPITATION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RHEUMATIC DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; AUTOIMMUNE DISEASES; DNA HELICASES; HLA-DP ANTIGENS; HUMANS;

EID: 13444283319     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.20766     Document Type: Article

References (14)

1. Smider V, Rathmell WK, Lieber MR, Chu G. Restoration of x-ray resistance and V (D)J recombination in mutant cells by Ku cDNA. Science 1994;266:288-91.
2. Mimori T, Akizuki M, Yamagata H, Inada S, Yoshida S, Homma M. Characterization of a high molecular weight acidic nuclear protein recognized by autoantibodies in sera from patients with polymyositis-scleroderma overlap. J Clin Invest 1981;68:611-20.
3. Reeves WH. Use of monoclonal antibodies for the characterization of novel DNA-binding proteins recognized by human autoimmune sera. J Exp Med 1985;161:18-39.
4. Wang J, Satoh M, Kabir F, Shaw M, Domingo MA, Mansoor R, et al. Increased prevalence of autoantibodies to Ku antigen in African American versus white patients with systemic lupus erythematosus. Arthritis Rheum 2001;44:2367-70.
5. Francoeur AM, Peebles CL, Gompper PT, Tan EM. Identification of Ki (Ku, p70/p80) autoantigens and analysis of anti-Ki autoantibody reactivity. J Immunol 1986;136:1648-53.
6. Hirakata M, Mimori T, Akizuki M, Craft J, Hardin JA, Homma M. Autoantibodies to small nuclear and cytoplasmic ribonucleoproteins in Japanese patients with inflammatory muscle disease. Arthritis Rheum 1992;35:449-56.
7. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med 1975;292:344-7.
8. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
9. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
10. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Caucado EL, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929-38.
11. Inoko H, Ota M. PCR-RFLP. In: J. Bidwell, KM Hui, editors. Handbook for HLA tissue-typing techniques. Boca Raton (FL): CRC Press; 1993. p. 9-70.
12. Yaneva M, Arnett FC. Antibodies against Ku protein in sera from patients with autoimmune diseases. Clin Exp Immunol 1989;76:366-72.
13. Imanishi T, Akaza T, Kimura A, Tokunaga K, Gojobori T. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In: Tsuji K, Aizawa M, Sasazuki T, editors. HLA 1991: proceedings of the Eleventh International Histocompatibility Workshop and Conference. Oxford: Oxford University Press; 1992. p. 1066-222.
14. Dong RP, Kimura A, Okubo R, Shinagawa H, Tamai H, Nishimura Y, et al. HLA-A and DPB1 loci confer susceptibility to Graves' disease. Hum Immunol 1992;35:165-72.